Phase 1/2, Open-Label, Multiple Ascending Dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ701 in Adults with ENPP1 Deficiency

被引：0
|
作者：
Sabbagh, Yves [1 ]
Wermers, Robert [2 ]
Fuhr, Rainard [3 ]
Schnabel, Dirk [4 ]
Arnason, Terra [5 ]
Besancon, Alix [6 ]
Cizman, Borut [1 ]
Wenkert, Deborah [7 ]
Gunter, Kurt [1 ]
机构：
[1] Inozyme Pharma, Boston, MA USA
[2] Mayo Clin, Rochester, MN USA
[3] Parexel Int GmbH, Early Phase Clin Unit, Berlin, Germany
[4] Charite, Ctr Chron Sick Children, Pediat Endocrinol, Berlin, Germany
[5] Univ Saskatchewan, Div Endocrinol, Saskatoon, SK, Canada
[6] Hop Univ Necker Enfants Malades, Endocrinodiabetol Pediat, Paris, France
[7] Wenkert & Young LLC, Thousand Oaks, CA USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SUN-504
引用
收藏
页码：376 / 377
页数：2
相关论文
共 50 条
  • [1] A Phase 1/2, Open-Label, Multiple Ascending Dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Adults with ENPP1 Deficiency
    Sabbagh, Yves
    Wermers, Robert
    Fuhr, Rainard
    Schnabel, Dirk
    Arnason, Terra
    Besancon, Alix
    Cizman, Borut
    Wenkert, Deborah
    Gunter, Kurt
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 72 - 72
  • [2] A Phase 1/2, Open-Label, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 Followed by an Open-Label Long-Term Extension Period in Adults with ABCC6 Deficiency Manifesting as Pseudoxanthoma Elasticum (PXE): An Interim Analysis
    Sabbagh, Yves
    Shenouda, Magdy
    Taubel, Jorg
    Lebwohl, Mark
    Gunter, Kurt
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 72 - 72
  • [3] Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study
    Bach, Thanh
    Galbiati, Shirley
    Kennedy, Jessie K.
    Deye, Gregory
    Nomicos, Effie Y. H.
    Codd, Ellen E.
    Garcia, Hector H.
    Horton, John
    Gilman, Robert H.
    Gonzalez, Armando E.
    Winokur, Patricia
    An, Guohua
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [4] A Phase 1, Open-label, Dose-escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1850 in Adults With Hypophosphatasia
    Dahir, Kathryn
    Dunn, Derek
    Hasan, Jawad
    Shannon, Amy
    Pan, Wei-Jian
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 374 - 374
  • [5] A Phase 1, Open-label, Dose-escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1850 in Adults With Hypophosphatasia
    Dahir, Kathryn
    Dunn, Derek
    Hasan, Jawad
    Shannon, Amy
    Pan, Wei-Jian
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 70 - 70
  • [6] A PHASE 1, OPEN-LABEL, DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ALXN1850 IN ADULTS WITH HYPOPHOSPHATASIA
    Dahir, K.
    Dunn, D.
    Mitter, S.
    Hasan, J.
    Shannon, A.
    Pan, W.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S43 - S44
  • [7] A PHASE 1, OPEN-LABEL, DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ALXN1850 IN ADULTS WITH HYPOPHOSPHATASIA
    Dahir, K.
    Dunn, D.
    Mitter, S.
    Hasan, J.
    Shannon, A.
    Pan, W.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S191 - S192
  • [8] SEAPORT 1: An Open-label Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Participants with ESKD Undergoing Hemodialysis: Interim Analysis
    Chaudhry, Asghar A.
    Zeig, Steven
    Fisch, Bruce Jeffrey
    Sabbagh, Yves
    Gunter, Kurt C.
    Nigwekar, Sagar U.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [9] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ENSIFENTRINE IN HEALTHY CHINESE ADULTS: A PHASE 1, OPEN-LABEL, SINGLE AND MULTIPLE DOSE STUDY
    Meng, Haijin
    Li, Xin
    Chen, Charlie
    Cheng, Cecilia
    Zhang, Ping
    Yuan, Chenchen Zhang
    CHEST, 2024, 166 (04) : 4758A - 4758A
  • [10] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF OXFENDAZOLE IN HEALTHY ADULTS IN AN OPEN LABEL PHASE 1 MULTIPLE ASCENDING DOSE AND FOOD EFFECT STUDY.
    Bach, T.
    Galbiati, S.
    Kennedy, J.
    Deye, G.
    Nomicos, E.
    Codd, E.
    Garcia, H.
    Horton, J.
    Gilman, R.
    Gonzalez, A.
    Winokur, P.
    An, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S17 - S17
12345